文献速递特殊人群用药治疗药物监测与药物基因组学

MPRINT Hub数据、模型、知识与研究协调中心:通过数据整合与定量药理学弥合母婴-儿科治疗研究差距

The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal-pediatric therapeutics research through data integration and pharmacometrics.
PubMed 文献 · Pharmacotherapy · 2023-01-25

孕产妇和儿科人群因临床试验纳入有限而长期被视为「治疗孤儿」,其生理变化会改变药物的药代动力学与药效学。美国NICHD设立MPRINT Hub以推动母婴-儿科精准治疗研究,本文概述该领域现状并介绍印第安纳大学-俄亥俄州立大学MPRINT Hub数据、模型、知识与研究协调中心(DMKRCC),其通过整合评估现有知识、支持定量药理学与临床试验设计、开发真实世界证据资源、开展教育及建立合作来促进研究。

要点

  • 孕产妇和儿科人群因临床试验纳入有限而被称为「治疗孤儿」。
  • 妊娠、哺乳及儿童生长发育会改变药物的PK与PD。
  • 整合多项研究数据(如PBPK/PD建模或生物信息学)可提升数据价值并识别认知缺口。

核心结论

  • DMKRCC将通过促进现有数据和资源的使用来识别知识缺口,并支持弥合这些缺口以提升母婴-儿科精准治疗。

研究设计与样本

  • 本文为概述性文章,介绍母婴-儿科治疗研究现状及NICHD设立的MPRINT Hub下属DMKRCC的目标与功能。

主要发现

  • 孕产妇和儿科人群因临床试验纳入有限而长期被视为「治疗孤儿」。
  • 妊娠和哺乳期的生理变化以及儿童的生长成熟会改变药物的PK和PD。
  • 支持这些人群精准治疗的研究往往规模小,单独影响有限。
  • 通过PBPK/PD建模或生物信息学方法整合不同研究的数据可增强数据价值并帮助识别理解缺口。

临床怎么用

  • 临床可关注DMKRCC在整合现有知识、支持定量药理学与临床试验设计、开发真实世界证据资源及教育协作方面的资源与工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Maternal and pediatric populations have historically been considered "therapeutic orphans" due to their limited inclusion in clinical trials. Physiologic changes during pregnancy and lactation and growth and maturation of children alter pharmacokinetics (PK) and pharmacodynamics (PD) of drugs. Precision therapy in these populations requires knowledge of these effects. Efforts to enhance maternal and pediatric participation in clinical studies have increased over the past few decades. However, studies supporting precision therapeutics in these populations are often small and, in isolation, may have limited impact. Integration of data from various studies, for example through physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling or bioinformatics approaches, can augment the value of data from these studies, and help identify gaps in understanding. To catalyze research in maternal and pediatric precision therapeutics, the Obstetric and Pediatric Pharmacology and Therapeutics Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) established the Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub. Herein, we provide an overview of the status of maternal-pediatric therapeutics research and introduce the Indiana University-Ohio State University MPRINT Hub Data, Model, Knowledge and Research Coordination Center (DMKRCC), which aims to facilitate research in maternal and pediatric precision therapeutics through the integration and assessment of existing knowledge, supporting pharmacometrics and clinical trials design, development of new real-world evidence resources, educational initiatives, and building collaborations among public and private partners, including other NICHD-funded networks. By fostering use of existing data and resources, the DMKRCC will identify critical gaps in knowledge and support efforts to overcome these gaps to enhance maternal-pediatric precision therapeutics.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Quinney SK, Bies RR, Grannis SJ, et al. The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal-pediatric therapeutics research through data integration and pharmacometrics. Pharmacotherapy. 2023. PMID: 36625779. doi:10.1002/phar.2765

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。